Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 890

1.

Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.

Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H.

Oncol Rep. 2010 Jun;23(6):1625-33.

PMID:
20428818
2.

MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.

Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM, Xu LY.

J Surg Oncol. 2012 Feb;105(2):175-82. doi: 10.1002/jso.22066. Epub 2011 Aug 22.

PMID:
21882196
3.

Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).

Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Sakurai D, Fujimura L, Kawakami K, Chiyomaru T, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N.

J Hum Genet. 2011 Aug;56(8):595-601. doi: 10.1038/jhg.2011.66. Epub 2011 Jul 14.

PMID:
21753766
5.

Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.

Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B, Waldron J, Gullane P, Cummings B, Liu FF.

Clin Cancer Res. 2010 Feb 15;16(4):1129-39. doi: 10.1158/1078-0432.CCR-09-2166. Epub 2010 Feb 9.

6.

Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.

Isozaki Y, Hoshino I, Nohata N, Kinoshita T, Akutsu Y, Hanari N, Mori M, Yoneyama Y, Akanuma N, Takeshita N, Maruyama T, Seki N, Nishino N, Yoshida M, Matsubara H.

Int J Oncol. 2012 Sep;41(3):985-94. doi: 10.3892/ijo.2012.1537. Epub 2012 Jun 28.

PMID:
22752059
7.

MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells.

Matsushima K, Isomoto H, Yamaguchi N, Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S, Nagayasu T, Nakashima M, Ujifuku K, Mitsutake N, Ohtsuru A, Yamashita S, Korpal M, Kang Y, Gregory PA, Goodall GJ, Kohno S, Nakao K.

J Transl Med. 2011 Mar 22;9:30. doi: 10.1186/1479-5876-9-30.

8.

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.

J Clin Oncol. 2009 Apr 20;27(12):2030-7. doi: 10.1200/JCO.2008.19.4134. Epub 2009 Mar 9.

PMID:
19273703
9.

Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.

Yang M, Liu R, Sheng J, Liao J, Wang Y, Pan E, Guo W, Pu Y, Yin L.

Oncol Rep. 2013 Jan;29(1):169-76. doi: 10.3892/or.2012.2105. Epub 2012 Oct 23.

PMID:
23124769
10.

Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.

Ann Surg Oncol. 2009 Sep;16(9):2494-501. doi: 10.1245/s10434-009-0559-5. Epub 2009 Jun 13.

PMID:
19526206
11.

Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers.

Nurul-Syakima AM, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A, Learn-Han L.

Int J Mol Med. 2011 Sep;28(3):327-36. doi: 10.3892/ijmm.2011.714. Epub 2011 Jun 1.

PMID:
21637912
12.

Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck--hallmark of epithelial-mesenchymal transition.

Zidar N, Boštjančič E, Gale N, Kojc N, Poljak M, Glavač D, Cardesa A.

Hum Pathol. 2011 Apr;42(4):482-8. doi: 10.1016/j.humpath.2010.07.020. Epub 2011 Jan 15.

PMID:
21237487
13.

Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.

Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA.

Laryngoscope. 2004 Dec;114(12):2063-72.

PMID:
15564824
14.

Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.

Gong H, Song L, Lin C, Liu A, Lin X, Wu J, Li M, Li J.

Clin Cancer Res. 2013 Mar 1;19(5):1083-93. doi: 10.1158/1078-0432.CCR-12-3169. Epub 2013 Jan 14.

15.

The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.

Hong L, Han Y, Zhang H, Li M, Gong T, Sun L, Wu K, Zhao Q, Fan D.

Ann Surg. 2010 Jun;251(6):1056-63. doi: 10.1097/SLA.0b013e3181dd4ea9.

PMID:
20485139
16.

[Differential expression of hsa-miR-126 and hsa-miR-518b in esophageal squamous carcinoma].

Cai H, Wang JS, Zhang MX, Duan XY, Ma RQ.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 Jan;31(1):23-7. Chinese.

17.

MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.

Meyer-Rochow GY, Jackson NE, Conaglen JV, Whittle DE, Kunnimalaiyaan M, Chen H, Westin G, Sandgren J, Stålberg P, Khanafshar E, Shibru D, Duh QY, Clark OH, Kebebew E, Gill AJ, Clifton-Bligh R, Robinson BG, Benn DE, Sidhu SB.

Endocr Relat Cancer. 2010 Aug 16;17(3):835-46. doi: 10.1677/ERC-10-0142. Print 2010 Sep.

18.

Over- and under-expressed microRNAs in human colorectal cancer.

Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M.

Int J Oncol. 2009 Apr;34(4):1069-75.

PMID:
19287964
19.

The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.

Zhang T, Wang Q, Zhao D, Cui Y, Cao B, Guo L, Lu SH.

Clin Sci (Lond). 2011 Nov;121(10):437-47. doi: 10.1042/CS20110207.

PMID:
21658006
20.

Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.

Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Alvarez-Alija G, Casado-Zapico S, Fresno MF, Rodríguez C, Suárez C, García-Pedrero JM.

J Pathol. 2010 Aug;221(4):402-10. doi: 10.1002/path.2722.

PMID:
20593490

Supplemental Content

Support Center